Anti-human IL-1R7 antibody (University of Colorado Denver Anschutz Medical Campus)

N/A

Report date: 2024/11/04 16:02:11

Base Information

Drug NameAnti-human IL-1R7 antibody (University of Colorado Denver Anschutz Medical Campus)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin 18 receptor inhibitors
TargetsInterleukin 18 receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Macrophage Activation Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado DenverMAB Discovery GmbH
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado DenverMAB Discovery GmbH
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Macrophage Activation Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A